Shaping Technion’s Human Health and Cancer Research

Featuring Technion President Uri Sivan and Distinguished Professor and Nobel Laureate Aaron Ciechanover | Moderated by Andrea Wolfe

When all is said and done, the coronavirus pandemic brought seismic changes and new ethical questions to the world of medicine. And the Technion was ready.

Learn about the Technion’s major initiative aimed at advancing the standard of healthcare in the 21st century, and to talk about science and ethics in the wake of coronavirus.

Technion medical breakthroughs have already saved lives around the world, thanks in large part to support from devoted Technion Guardians. Now, in an intimate conversation followed by a Q&A session, Technion President Uri Sivan shares his vision for the new Technion Human Health Initiative (THHI). Launched in August 2020, the THHI combines the expertise of research and teaching hospitals with Technion faculties and industry partners in pharma and biomedicine. This undertaking is one of the Technion’s largest investments and is critical to the future of Israel.

Distinguished Professor Aaron Ciechanover, founder of the Rappaport Technion Integrated Cancer Center (RTICC), updates participants on the exciting results of Technion cancer projects and his own latest research. He also discusses contemporary ethical aspects emerging from the coronavirus pandemic, and the revolution of personalized medicine.

Click on the image above to experience this webinar.